ARTI-CELL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ARTI-CELL Trademark

Serial Number: 79230342 • Registration: 5609195

ARTI-CELL is a trademark filed by Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap on February 26, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap (5 trademarks)

Noorwegenstraat 4

Entity Type: 78

GLOBAL STEM CELL TECHNOLOGY, besloten vennootschap met beperkte aansprakelijkheid (3 trademarks)

Noorwegenstraat 4
Evergem B-9940 , BE

Entity Type: 78

Trademark Details

Filing Date

February 26, 2018

Registration Date

November 20, 2018

Published for Opposition

September 4, 2018

Cancellation Date

July 7, 2025

Goods & Services

Stem cells for veterinary use; surgical implants comprising living tissue and grown from stem cells; veterinary preparations for the prevention and treatment of articular and cartilage damage and injuries; vitamin preparations for the purpose of supporting stem cell physiology; dietary supplements for the purpose of supporting stem cell physiology; pharmaceutical preparations, in the form of injectable gels, powders, tablets and fluids for preventing and treating of articular and cartilage damage and injuries for humans and animals

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Jan 22, 2026 DETH
CANCELLED SECTION 71
Jun 6, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Jun 3, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 31, 2021 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2019 FINV
GENERIC MADRID TRANSACTION SENT TO IB
Feb 28, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 28, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 20, 2019 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 24, 2019 ADCH
REGISTERED-PRINCIPAL REGISTER
Nov 20, 2018 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 4, 2018 NREP
PUBLISHED FOR OPPOSITION
Sep 4, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 31, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 15, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 15, 2018 OP2R
NOTICE OF PUBLICATION
Aug 15, 2018 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 24, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2018 TROA
REFUSAL PROCESSED BY IB
May 25, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 10, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 10, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 8, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 7, 2018 CNRT
ASSIGNED TO EXAMINER
May 2, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 20, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 13, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Apr 12, 2018 SDRC